5 completed, 1 unknown. 2 Phase 3, 2 Phase 4, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 4 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Glulisine: new trials by email Literature Review of Glulisine trials Research Report on Glulisine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficiency of Linagliptin (Trajenta) in the Setting of Internal Medicine Department Linagliptin and Basal Insulin, Basal Insulin and Bolus Insulin - DM2 | Phase 3 | Unknown | Rabin Medical Center | 60 | 2017-10-01 | 2017-09-11 |
| Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS) Apidra, current insulin - Type 1 Diabetes, Lipoatrophy | Phase 4 | Completed | Kinderkrankenhaus auf der Bult | 14 | 2016-09-01 | 2024-10-15 |
| CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) Commercial Hylenex® recombinant (hyaluronidase human injection), Precommercial Hylenex recombinant (hyaluronidase human injection), Insulin lispro - Type 1 Diabetes Mellitus | Phase 4 | Completed | Halozyme Therapeutics | 456 | 2013-03-01 | 2018-11-07 |
| Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients Metformin, Glargine insulin, Glulisine - Poor Glycemic Control | Phase 3 | Completed | Emory University | 175 | 2012-10-01 | 2018-09-24 |
| Comparison on Efficacy and Safety of Three Inpatient Insulin Therapy in Type2 DM regular insulin, 70/30 insulin, Glargine - Diabetes Mellitus (DM) | Not applicable | Completed | Cairo University | 63 | 2010-03-01 | 2019-01-15 |
| A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs Alone Recombinant human hyaluronidase PH20 (rHuPH20), Insulin lispro, Insulin glulisine - Healthy | Phase 1 | Completed | Halozyme Therapeutics | 14 | 2009-09-01 | 2014-07-14 |
Diabetes Mellitus (2) · Diabetes Mellitus, Type 1 (2) · Insulin Resistance (1) · Lipodystrophy (1)
Halozyme Therapeutics (2) · Cairo University (1) · Emory University (1) · Kinderkrankenhaus auf der Bult (1) · Rabin Medical Center (1)
United States (3) · Egypt (1)
Douglas Muchmore, MD (1) · Guillermo E Umpierrez, MD (1) · Marcus Hompesch, M.D. (1) · Olga Kordonouri, MD (1)